CFM
BIO icon

Catalyst Funds Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Catalyst Funds Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,300
Closed -$1.21M – 357
2025
Q3 		$1.21M Buy
4,300
+1,725
+67% +$469K 0.18% 123
2025
Q2 		$621K Buy
2,575
+875
+51% +$207K 0.17% 164
2025
Q1 		$414K Sell
1,700
-3,000
-64% -$902K 0.11% 215
2024
Q4 		$1.54M Hold
4,700
– – 0.38% 55
2024
Q3 		$1.57M Buy
+4,700
New +$1.49M 0.35% 52

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return